Several weeks ago, I shared new microgreens beverage research in a commercial growers group. The response from one enterprise-scale operator stopped me cold. They had run the numbers, sat across from nutraceutical buyers, and watched the unit economics fail. Their verdict: forget juicing them.
They were right about today. But the research building behind microgreens beverages and supplements since 2025 points somewhere different. Science, harsh commercial reality, and an almost complete absence of human clinical data are all pointing in the same direction and pulling in opposite directions at the same time.
This post lays out what we actually know, what the economics show, and where the real opportunity sits for growers paying close attention.
Key Takeaways
Four studies published between 2025 and 2026 confirm that microgreens retain meaningful bioactive compounds in beverages under cold storage. Only one randomized controlled human trial on microgreens consumption exists (Lee et al., 2025), and it tested feasibility, not health outcomes. The commercial case is real but not yet economically viable at scale.
Below you will find what the newest research actually measured, why the unit economics wall is structural rather than temporary, what one human trial tells us, and where the real opportunity sits for growers watching this category carefully.
What does the science actually say about microgreens beverages and supplements?
The nutritional story of microgreens did not start with beverages. It started in 2012, when Xiao et al. published the first major assessment of vitamin and carotenoid concentrations in microgreens and found they contained significantly higher concentrations than their mature counterparts. That finding set off a research cascade that has not stopped.
By 2022, a comprehensive review by Jambor et al. documented anti-cancer, anti-inflammatory, anti-diabetic, antimicrobial, and antioxidant properties across multiple microgreens species, with phytochemical concentrations documented at 10 to 100 times higher than adult plant equivalents. The review also noted what was missing: validated health effects in human studies.
The move toward processed microgreen products began gaining research momentum in 2025. Four studies deserve attention from anyone tracking microgreens beverages and supplements as a commercial category.
A 2025 study in Food Chemistry: X optimized a microgreens-based lassi using radish sango microgreens, achieving a formulation with 44.14 mg of phenolics per 100g, 22.62 mg of flavonoids, and 59.32 mg of ascorbic acid. Consumer acceptability scored 8.29 on a 9-point hedonic scale. Shelf-life modeling projected a 9.33-day half-life at five degrees Celsius (Gunjal et al., 2025).
A 2026 study developed a hydroalcoholic extract beverage from beetroot and tarragon microgreens, evaluated over 15 days under refrigeration. Tarragon microgreens protected beetroot betalain pigments from degradation, reducing color change by more than 80 percent. Antioxidant activity measured by TEAC increased approximately 37 percent from day one to day ten (Processes, 2026).
Cold-pressed beet microgreen juice showed phenolic content of 73.48 mg GAE per 100 mL and flavonoid content of 47.26 mg QE per 100 mL. Cold-pressing specifically is emerging as the superior extraction method because it minimizes thermal degradation of thermolabile phytonutrients that conventional processing destroys (Processes, 2025).
A June 2026 study in the Journal of Food Process Engineering evaluated microgreen-based ready-to-serve beverages across bioactive compound concentrations, consumer acceptability, and shelf-life stability using kinetic modeling. Bioactive retention was meaningful. Consumer response was positive (Gunjal et al., 2026).
Taken together, the science confirms one thing clearly: microgreens can be incorporated into processed beverages without losing the nutritional density that makes them valuable. The compounds survive. The consumers respond positively. The shelf-life window under cold storage is real, if narrow.
Why are the unit economics of microgreens beverages so difficult right now?
The research does not model what happens when a grower actually tries to build a business around processed microgreens products. Commercial operators who have tried to tell a different story from the journals.
Start with the raw yield math. Using broccoli microgreens as the benchmark, a standard 1020 tray seeded at pro level produces approximately 300g of fresh material. At 90 to 91 percent moisture content, the verified range for cold-pressed vegetable juices (Stajcic et al., 2025), the theoretical juice yield is approximately 270g per tray, or roughly 9 fluid ounces. At beginner yield ratios, the number drops to under 2 fluid ounces per tray. Even at the pro level, filling a single 16 fl oz retail bottle requires nearly two fully grown trays of broccoli microgreens.
The cost structure compounds from there. Processing culls and trims costs more than the revenue they generate. Collection, cleaning, juicing, and packaging add labor and equipment costs on top of an already thin-margin operation. At enterprise scale, where packaging of fresh-cut microgreens is streamlined and largely automated, the additional cost of processing is not absorbed by efficiency. It compounds it.
Freeze-drying is the format most commonly cited as viable for microgreens supplements, and it is barely profitable even at scale. A sixteen-fluid-ounce retail bottle at ten to twelve dollars does not leave enough margin after processing, packaging, distribution, and retail markup. Beverage and nutraceutical companies that have sat across the table from commercial microgreens operators have been direct about the price tolerance problem: the market will not pay what the product costs to make.
The pasteurization wall makes it worse. Heat treatment, the standard solution to shelf-life problems in beverage manufacturing, destroys the thermolabile phytonutrients that justify the premium price in the first place. Cold storage at five degrees Celsius preserves bioactive stability for nine to fifteen days, depending on formulation. That window works for a direct-to-consumer or tight regional model. It does not work for national retail.
The Amazon supplement market tells a more encouraging story on price tolerance. True Grace Broccoli Microgreens powder sells at $26.97 for 30 servings. Small-batch whole food microgreen powder blends are priced between $25 and $60 per unit with strong ratings and low review volumes. The consumer who pays that price already exists. The mass distribution infrastructure that would make it viable at scale does not exist yet.
If you want to model the yield and cost numbers for your specific variety and growing setup, the Microgreens Profitability Calculator at microgreensworld.com runs the math by tray, by variety, and by skill level. The gap between what science promises and what economics currently allows becomes very clear very fast.
That gap between small-batch viability and enterprise-scale economics is where the microgreens beverages and supplements opportunity actually lives right now.
What do consumers actually think about microgreens beyond the plate?
Consumer research on microgreens has been building in parallel with the nutrition science, and the findings are more encouraging than the unit economics.
A 2024 study surveying 150 consumers aged 20 to 35 found that 100 were already familiar with microgreens, with a strong positive inclination toward their health benefits for personal and gut health. Barriers included lack of awareness, perishability concerns, and price sensitivity (Rawat et al., 2024). A 2020 Colorado State University consumer study with 99 participants tested six microgreens species and found that all varieties received high mean acceptability scores. Key drivers of purchase intent included knowledge, availability, freshness, and cost. Food neophobia was the primary barrier (Michell et al., 2020).
What neither of those studies measured was consumer response to microgreens in processed form. The beverage and powder research from 2025 and 2026 begins to fill that gap. Consumer panels in the lassi study scored acceptability at 8.29 on a 9-point scale. The cold-pressed juice study found strong sensory scores for color, aroma, and taste. The RTS beverage study found positive consumer response to the finished product.
The most useful data point for understanding where consumer demand actually sits right now is the Amazon supplement market. Products with five-star ratings and twelve to thirty-eight reviews at $25 to $60 per unit are not volume sellers. But they are proof-of-concept at a premium price point. The consumer who seeks out microgreens in supplement or powder form is health-conscious, research-aware, and willing to pay significantly above commodity food pricing for a product with a documented nutritional story.
Education and availability remain the rate limiters, not desire. When consumers understand what microgreens contain and why it matters, they respond. The work of building that understanding has historically fallen on independent growers with no marketing budget. That is about to change as institutional money enters the category.
What regulatory and food safety risks come with processing microgreens?
Fresh microgreens are classified as produce under current FDA frameworks. The moment you juice them, powder them, encapsulate them, or make any processing-based claim about their bioactive content, the classification question changes.
Processed microgreen products may cross into dietary supplement or functional food territory depending on the form and the claims made about them. That classification shift matters because it changes labeling requirements, permissible health claims, compliance costs, and the language permitted in marketing. Structure-function claims are permissible under DSHEA with proper substantiation. Disease treatment claims are not, regardless of what the research shows.
The good news is that no special regulatory barrier applies uniquely to microgreens. The framework that governs broccoli sprout extracts, moringa powder, and wheatgrass supplements applies equally here. Well-backed research combined with careful language that avoids medical or clinical implications is the established path. The supplement market has decades of precedent for navigating this correctly.
The risk worth watching is what happens when institutional capital scales this category at retail volume. The FDA has a documented pattern of increasing oversight when a niche food category begins moving at mainstream scale. The sprout regulation history is the cautionary parallel. Microgreens currently sit outside the sprout rule. That boundary may not remain fixed if major players begin selling processed microgreens products at national retail volume.
Anyone building a microgreens beverages or supplements business right now should build it with regulatory tightening already factored in. The compliance investment that feels premature at small-batch scale is the exact investment that protects the business when the category attracts regulatory attention. GAP certification is the minimum baseline. It opens distribution channels and signals food safety credibility to buyers who are tightening their supplier requirements.
Does juicing or powdering microgreens actually deliver more nutrition than eating them whole?
This is the question the research has not yet answered, and it is the most important one for anyone building a processed microgreens product.
The case for juicing microgreens specifically, rather than waiting for them to mature, starts with when phytochemical concentration peaks. The cotyledon stage, when microgreens are harvested, appears to be when certain bioactive compounds are at their most concentrated. As the plant matures and directs energy toward root development and stem extension, that concentration tends to dilute across greater plant mass rather than accumulate (Xiao et al., 2012). More volume per tray does not mean more bioactive yield per unit of juice produced.
Retention is not the same as absorption. The 2025 and 2026 beverage studies consistently demonstrate that bioactive compounds survive processing and cold storage. They do not establish that those compounds are more bioavailable in beverage or powder form than in whole plant form consumed fresh.
The sulforaphane case illustrates why this matters. Cutting or chewing broccoli microgreens activates myrosinase, the enzyme that converts glucoraphanin into sulforaphane, the anticarcinogenic compound documented in broccoli research going back to Fahey et al. (1997). That enzymatic activation is a mechanical process that happens in the plant tissue at the moment of cell disruption. What happens to that activation pathway when the plant is cold-pressed, freeze-dried, or encapsulated is a separate scientific question.
The juice yield reality compounds the question further. Microgreen juice runs approximately 89 to 91 percent moisture by weight, consistent with the verified range for cold-pressed vegetable juices (Stajcic et al., 2025). That sounds high until you account for the wet-to-dry ratio of the plant material going in. The juice yield per unit of fresh microgreen weight is considerably lower than most people expect. Letting microgreens grow another week adds fresh weight but adds cost too, and the same shelf life wall waits at the other end regardless of growth stage.
The 2022 Jambor review explicitly identified the core gap, listing “determining bioaccessibility” and “validation of health-promoting effect in human studies” as critical unresolved areas in microgreens research. Until that gap closes, the supplement and functional beverage thesis rests on strong but incomplete science. That is not a reason to avoid the space. It is a reason to position carefully, speak accurately, and avoid claims the research cannot yet support.
The microgreens beverages and supplements category needs the bioavailability data that only human trials can provide.
Where is the actual human trial data on microgreens, and why does it matter?
As of June 2026, there is exactly one published randomized controlled human trial on microgreens consumption in the peer-reviewed literature.
According to PubMed, Lee, Michell, et al. at Colorado State University published a crossover trial in Nutrients in January 2025 (Lee et al., 2025). Twenty-six healthy middle-aged and older adults consumed either bull’s blood beet or red cabbage microgreens daily for two weeks. Compliance reached 95.6 percent. The primary finding was feasibility and tolerability. One secondary finding: improvement in gastrointestinal inflammation-associated symptom severity scores following red cabbage microgreens. No changes in hemodynamic parameters or gut microbiota diversity were observed. The researchers themselves called for “future studies designed to evaluate their health impacts.”
That is the entirety of the human clinical record on microgreens. One feasibility study. No long-term efficacy data. No studies targeting specific chronic disease outcomes. No studies on processed forms.
This is simultaneously the biggest weakness in the microgreens supplements thesis and the biggest opportunity in the category.
Every functional food category that has crossed from niche to mainstream has done so on the back of human clinical data. Omega-3 fatty acids had trials. Probiotics had trials. Microgreens do not yet have that anchor study.
The institutional capital now entering the category through acquisitions will eventually pull clinical research dollars behind it. A company with the scale of an institutionally backed operation has both the incentive and the resources to fund the human trial data that would reposition microgreens from specialty produce to a documented functional ingredient.
That study is probably three to five years away. When it arrives, the category narrative changes overnight. The growers and entrepreneurs positioned before that moment capture the upside.
What does the blue ocean opportunity actually look like for growers and entrepreneurs?
The fresh-cut retail market is consolidating. Fresh Origins and Flavour Fields hold the top tier in dedicated microgreens volume and foodservice penetration in the United States. The recent Palm Ventures acquisition of AeroFarms signals institutional capital entering the Tier 2 position at national retail scale.
That is the red ocean. Larger, better-capitalized operations are competing for shelf space and foodservice contracts at volume and price. Independent growers who try to compete directly on those terms will be squeezed.
The nutrition play is different. Small-batch microgreen powder products on Amazon are already selling at $25 to $60 per unit with strong ratings. The consumer exists. The price tolerance exists at premium positioning. The distribution infrastructure that would make it viable at a commodity scale does not exist yet.
The grower or entrepreneur who wants to compete in the microgreens beverages and supplements space needs several things that the typical fresh-cut producer does not currently have. GAP certification is the non-negotiable baseline. It opens conversations with distributors, retailers, and foodservice buyers who are tightening supplier requirements. Wholesale scale likely requires pooling resources with other local growers rather than reaching processing volumes alone. A product story grounded in research rather than marketing language is what justifies the premium price point and survives regulatory scrutiny.
The business model that makes the most sense right now is not a grower trying to become a beverage company. It is a grower who becomes a trusted raw material supplier for the right formulator, paired with content authority that builds direct consumer demand for the category. The licensing model, where deep knowledge about microgreens nutrition is packaged and partnered with producers rather than internalized into a single manufacturing operation, may be the most capital-efficient path for anyone not already operating at enterprise scale.
The window between the science being ready and the economics catching up is the most interesting place to be in this industry right now.
Wrap-up: microgreens beverages and supplements; where the industry actually stands
The research confirms that microgreens retain meaningful bioactives in cold-pressed juices, fermented beverages, and powder formats. Four studies from 2025 and 2026 point toward a real category. One human trial confirmed feasibility and tolerability, not health outcomes.
The commercial operator who said the unit economics are genuinely horrible was telling the truth about today. The pasteurization wall is real. The shelf-life window is narrow. The price ceiling at mass retail is real. But small-batch supplement products on Amazon are already proving that the consumer exists and will pay a premium for a product with a documented nutritional story.
The growers who understand both sides of this right now will be positioned when institutional capital funds the human trials that move microgreens from promising to prescribed. That inflection point is probably three to five years out.
The microgreens beverages and supplements story is not fully written. The growers paying close attention to the research trajectory will be the ones writing the next chapter. If you want to see how this fits into building a sustainable microgreens business, the Microgreens World business hub covers the full picture.
Frequently asked questions about microgreens beverages and supplements
How do microgreens compare nutritionally to wheatgrass juice?
Wheatgrass juice has dominated the superfood beverage space for decades, but the phytochemical profiles are quite different. Wheatgrass delivers primarily chlorophyll and basic vitamins. Microgreens span a much wider bioactive range depending on the variety, including glucosinolates in brassica species and betalains in beet microgreens. The research base on microgreens is newer but growing faster than wheatgrass ever did.
Can home growers produce microgreens for supplement companies?
Not without meeting specific quality and certification requirements first. Supplement manufacturers sourcing raw plant material need suppliers who can document consistent phytochemical profiles and food safety practices. GAP certification is the baseline entry point. Specialty wholesale at this level is uncommon for small operations, but not impossible for growers who invest in the right infrastructure.
What is the difference between a microgreens powder and a greens powder supplement?
Greens powder supplements typically blend dozens of ingredients, including spirulina, chlorella, grasses, and vegetable extracts. A dedicated microgreens powder contains one or a small number of species, producing a more targeted phytochemical profile. The tradeoff is narrower nutritional coverage but potentially stronger bioactive concentration per gram of a specific target compound.
Do microgreens lose nutritional value when dried?
Drying method matters significantly. Freeze-drying preserves bioactive compounds more effectively than heat-based drying because it avoids thermal degradation of thermolabile phytonutrients. Spray-drying and oven-drying at high temperatures are generally incompatible with preserving the specific compounds that make microgreens nutritionally distinctive. The research on freeze-dried microgreens as a supplement ingredient is still early, but directionally positive.
Are microgreens beverages safe during pregnancy?
Fresh microgreens consumed as food are generally considered safe during pregnancy when properly grown and handled, similar to other fresh produce. Processed microgreen products in beverage or supplement form have not been studied in pregnant populations. Anyone who is pregnant should speak with their physician before adding any new functional beverage or supplement to their diet.
What is the shelf life of a freeze-dried microgreens powder?
Freeze-dried microgreens powder typically ranges from twelve to twenty-four months when stored in sealed, moisture-protected packaging away from light and heat. This extended shelf life is one reason freeze-drying is the most commercially viable processing format for microgreens supplements, despite higher processing costs compared to fresh or refrigerated products.
References
The following sources informed this analysis of microgreens beverages, supplements, and the emerging functional food category.
Fahey, J. W., Zhang, Y., & Talalay, P. (1997). Broccoli sprouts: An exceptionally rich source of inducers of enzymes that protect against chemical carcinogens. Proceedings of the National Academy of Sciences, 94(19), 10367–10372. https://doi.org/10.1073/pnas.94.19.10367
Gunjal, M., Khalangre, A., Singh, J., & Rasane, P. (2025). Novel approach for development and optimization of microgreens-based functional dairy beverage: Antioxidant enhancement, consumer acceptability, and kinetic shelf-life modeling. Food Chemistry: X, 28, 102559. https://doi.org/10.1016/j.fochx.2025.102559
Gunjal, M., Rasane, P., Singh, J., Kaur, S., Nanda, V., Ullah, R., Iqbal, Z., & Ercisli, S. (2024). Assessment of bioactive compounds, antioxidant properties, and morphological parameters in selected microgreens cultivated in soilless media. Scientific Reports, 14, Article 23605. https://doi.org/10.1038/s41598-024-73973-w
Gunjal, M., et al. (2026). Exploring the potential of microgreen-based RTS beverage: A comprehensive study on bioactive compounds, acceptability, and stability using kinetic models. Journal of Food Process Engineering. https://doi.org/10.1111/jfpe.70646
Jambor, T., Knizatova, N., Valkova, V., Tirpak, F., Greifova, H., Kovacik, A., & Lukac, N. (2022). Microgreens as a functional component of the human diet: A review. Journal of Microbiology, Biotechnology and Food Sciences, 12(1), e5870. https://doi.org/10.55251/jmbfs.5870
Lee, S. Y., Michell, K. A., Butler, M. M., Smith, B. T., Woolf, E. K., Holmes, S. C., Grabos, L. E., Vazquez, A. R., Isweiri, H., Bunning, M., Uchanski, M. E., Rao, S., Newman, S. E., Weir, T. L., & Johnson, S. A. (2025). Feasibility and tolerability of daily microgreen consumption in healthy middle-aged/older adults: A randomized, open-label, controlled crossover trial. Nutrients, 17(3), 467. https://doi.org/10.3390/nu17030467
Michell, K. A., Isweiri, H., Newman, S. E., Bunning, M., Bellows, L. L., Dinges, M. M., Grabos, L. E., Rao, S., Foster, M. T., Heuberger, A. L., Prenni, J. E., Thompson, H. J., Uchanski, M. E., Weir, T. L., & Johnson, S. A. (2020). Microgreens: Consumer sensory perception and acceptance of an emerging functional food crop. Journal of Food Science, 85(4), 926–935. https://doi.org/10.1111/1750-3841.15075
Rawat, K., Pahuja, A., Sharma, R., & Jain, M. (2024). Microgreens: Acceptance and perception of consumers. Annals of Arid Zone, 63(4), 145–152. https://doi.org/10.56093/aaz.v63i4.147908
Stajcic, S., et al. (2025). Physicochemical and bioactive stability of a beetroot-tarragon microgreen beverage during refrigerated storage. Processes, 13, 3284. https://doi.org/10.3390/pr13113284
Xiao, Z., Lester, G. E., Luo, Y., & Wang, Q. (2012). Assessment of vitamin and carotenoid concentrations of emerging food products: Edible microgreens. Journal of Agricultural and Food Chemistry, 60(31), 7644–7651. https://doi.org/10.1021/jf300459b
